1 Some 2-alkylthio derivatives of adenosine 5 '-monophosphate (AMP), adenosine 5'-monophosphorothioate (AMPS) and adenosine 5'-triphosphate (ATP) were examined as inhibitors of human platelet aggregation.
Introduction
Adenosine 5'-diphosphate (ADP) is a physiologically important inducer of human platelet aggregation (Born, 1962) , and this aggregation can be inhibited by adenosine, adenosine 5'-monophosphate (AMP) and adenosine 5'-triphosphate (ATP) and some of their analogues (for a review see Haslam & Cusack, 1981) . Adenosine inhibits noncompetitively aggregation induced by ADP and other aggregating agents by acting at an adenosine receptor linked to adenylate cyclase (Haslam, 1973; Haslam & Rosson, 1975) . In contrast, ATP has been shown to be a specific, competitive ADP antagonist (Macfarlane & Mills, 1975) . AMP and adenosine 5'-monophosphorothioate (AMPS) are weak inhibitors of ADP-induced aggregation, but some of their 2-substituted analogues are much more potent and evidence suggests that they may act at the ADP receptor (Gough, Nobbs, Middleton, PenglisCaredes & Maguire, 1978) . 2-(Pentan-l-yl)thio-AMP ('2-n-amylthio-AMP') and 2-azido-AMP in-0007-1188/82/020397-04 $01.00 hibit ADP-induced human platelet aggregation but unlike adenosine do not cause increases in levels of platelet adenosine 3',5 '-cyclic monophosphate (cyclic AMP), and in addition 2-(pentan-l-yl)thio-AMP does not inhibit aggregation induced by 5-hydroxytryptamine (5-HT), adrenaline, vasopressin, arachidonic acid or endoperoxide analogues (Kikugawa, Suehiro & Ichino, 1973b; Maclntyre, Gordon, Drummond, Steer & Salzman, 1977; Cusack & Born, 1977; Cusack, Hickman & Born, 1979) . 2-Methylthio-and 2-ethylthio-derivatives of AMP and AMPS were potent inhibitors of sheep platelet aggregation induced by ADP but did not inhibit aggregation induced by 5-HT or thrombin (Maguire & De, 1978) . Since 2-alkylthio derivatives of AMP and AMPS have been proposed as specific, competitive antagonists of ADP-induced platelet aggregation (Michal, Maguire & Gough, 1969; MacIntyre etal., 1977) , we decided to investigate the nature of the inhibition in more detail.
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Methods
Human platelet-rich plasma was separated from citrated venous blood by centrifugation at 260 g for 20 min at room temperature. Aggregation was quantified photometrically (Michal & Born, 1971) as the maximal rate of increase in light transmission (arbitrary units/min) through a 0.5 ml sample of stirred platelet-rich plasma at 37°C on addition of a test methylthioadenosine, 2-ethylthioadenosine and 2-(pentan-l-yl)thioadenosine by alkylation with iodomethane, bromoethane and 1-bromopentane respectively (Kikugawa, Suehiro & Ichino, 1973a) . Phosphorylation of these adenosine analogues with phosphoryl chloride gave 2-methylthio-AMP, 2-ethylthio-AMP and 2-(pentan-l-yl)thio-AMP (Michal et al., 1969; Kikugawa et al., 1973b) , and 2-ethylthio-AMPS was obtained by thiophosphorylation of 2-ethylthioadenosine with thiophosphoryl chloride (Gough et al., 1978) . Pyrophosphorylation of 2-methylthio-AMP and 2-ethylthio-AMP with trin-butylammonium pyrophosphate and carbonyl diimidazole gave 2-methylthio-ATP and 2-ethylthio-ATP respectively (Gough, Maguire & Satchell, 1973) . All nucleotides were examined by high performance liquid chromatography and purified where necessary by ion exchange chromatography, and stock solutions were assayed by ultraviolet spectroscopy. induced aggregation, whereas the ATP analogues achieved about 60% inhibition in the same experiment. The rank order of potency of the AMP analogues was 2-ethylthio-AMPS> 2-ethylthio-AMP > 2-(pentan-1-yl)thio-AMP > 2-methylthio-AMP (Figure 2a) , and of the ATP analogues 2-methylthio-ATP was more potent than 2-ethylthio-ATP ( Figure 2b ).
Discussion
These results show that 2-methylthio-AMP, 2-ethylthio-AMP, 2-(pentan-l-yl)thio-AMP, 2-ethylthio-AMPS, 2-methylthio-ATP and 2-ethylthio-ATP each caused noncompetitive inhibition of ADP-induced human platelet aggregation. This inhibition was immediate and was specific for aggregation induced by ADP since these compounds did not inhibit aggregation induced by 11,9-epoxymethano PGH2, a stable endoperoxide analogue which acts at a prostaglandin receptor (MacIntyre, Salzman & Gordon, 1978) . This inhibition cannot be mediated by an action at the platelet adenosine receptor since inhibition by adenosine requires preincubation and is not specific for ADP (Haslam, 1973) .
Several nucleotides have been claimed to be ADP antagonists, but evidence for competitive antagonism has been presented only in the cases of ATP (Macfarlane & Mills, 1975) , 0,'y-methylene ATP (Born & Foulks, 1977; Evans, 1979) , some a,w-diadenosine 5'-polyphosphates (Harrison, Brossmer & ) and adenosine 5'-tetraphosphate (Harrison & Brossmer, 1976) . 2-Methylthio-AMP, 2-ethylthio-AMP, 2-ethylthio-AMPS and 2-(pentan-l-yl)thio-AMP have been shown to be specific inhibitors of ADP-induced aggregation, as they are inactive against other aggregating agents (Maguire & De, 1978; Maclntyre et al., 1977) , and our results with 11,9-epoxymethano PGH2 confirm this. 2-Methylthio-AMP and 2-(pentan-l-yl)thio-AMP have been stated to be competitive inhibitors of ADP-induced aggregation (Michal et al., 1969; Maclntyre et al., 1977) , but full log dose-response curves have not been presented and our results clearly show that the inhibition is noncompetitive. The effects of 2-alkylthio analogues of ATP on platelets have not hitherto been described, but 2-methylthio-ATP has been tested for its effects on guinea-pig taenia coli, where 2-methylthio-ATP and ATP both caused relaxation apparently by a similar mechanism (Gough et al., 1973) . Our results with human platelets show that 2-methylthio-ATP (and 2-ethylthio-ATP) do not inhibit ADP-induced aggregation by the same mechanism as ATP.
